The most promising AstraZeneca trial yet
AstraZeneca said Monday that the trial, which included 32,000 people, found the shot prevented symptomatic Covid-19 in 79% of people, and was 100% effective in preventing severe disease and hospitalization. It also filled a glaring data gap in the over 65s age group, showing an efficacy of 80% in symptomatic disease prevention, slightly higher than … Read more